F B Lillo

Summary

Affiliation: San Raffaele Scientific Institute
Country: Italy

Publications

  1. ncbi Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection
    F B Lillo
    Laboratory of Virology, AIDS Center San Luigi, IRCCS Hospital San Raffaele, Milan, Italy
    AIDS 13:791-6. 1999
  2. ncbi Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection
    Flavia B Lillo
    Laboratory of Virology, Scientific Institute San Raffaele, Milan, Italy
    Clin Infect Dis 40:451-7. 2005
  3. ncbi Few modifications of the Cobas Amplicor HIV Monitor 1.5 test allow reliable quantitation of HIV-1 proviral load in peripheral blood mononuclear cells
    Flavia B Lillo
    Laboratory of Virology, IRCCS Hospital San Raffaele, AIDS Center San Luigi, Via Stamira, D Ancona 20, 20127 Milan, Italy
    J Virol Methods 120:201-5. 2004
  4. ncbi Human papillomavirus viral load: a possible marker for cervical disease in HIV-infected women
    Flavia B Lillo
    Laboratory of Virology, AIDS Center San Luigi, Via Stamira d Ancona 20, San Raffaele Scientific Institute, 20127 Milan, Italy
    J Antimicrob Chemother 57:810-4. 2006
  5. ncbi Human papillomavirus infection and its role in the genesis of dysplastic and neoplastic lesions of the squamous epithelia
    Flavia B Lillo
    Laboratory of Virology, IRCCS Hospital San Raffaele, Milano, Italy
    New Microbiol 28:111-8. 2005
  6. ncbi HIV-1 DNA and RNA kinetics in primary HIV infection
    F Lillo
    Laboratory of Virology, Scientific Institute San Raffaele, Milan, Italy
    J Biol Regul Homeost Agents 16:49-52. 2002
  7. ncbi Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy
    F B Lillo
    Laboratory of Virology, San Raffaele Hospital, 20127 Milan, Italy
    J Infect Dis 184:547-51. 2001
  8. ncbi Granulocyte/monocyte apheresis induces sustained increases in CD4 T cells in HIV-1 infected patients with poor CD4 T cell restoration after suppression of viral replication by HAART
    H Hasson
    Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
    J Biol Regul Homeost Agents 16:58-63. 2002
  9. ncbi Ex-vivo purging of circulating monocytes results in immunovirologic improvement in partially HAART responder HIV-infected patients
    A Beretta
    CIRBS, Hospital St Joseph, Paris, France
    J Biol Regul Homeost Agents 14:27-31. 2000
  10. ncbi The effect of HAART on humoral immune response in primary HIV-1 infected patients
    C Pastori
    Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
    J Biol Regul Homeost Agents 16:9-17. 2002

Collaborators

Detail Information

Publications13

  1. ncbi Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection
    F B Lillo
    Laboratory of Virology, AIDS Center San Luigi, IRCCS Hospital San Raffaele, Milan, Italy
    AIDS 13:791-6. 1999
    ....
  2. ncbi Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection
    Flavia B Lillo
    Laboratory of Virology, Scientific Institute San Raffaele, Milan, Italy
    Clin Infect Dis 40:451-7. 2005
    ..The role of human papillomavirus (HPV) load and the importance of multiple-strain HPV infections as biomarkers for the development of cervical disease were evaluated in human immunodeficiency virus (HIV)-positive women...
  3. ncbi Few modifications of the Cobas Amplicor HIV Monitor 1.5 test allow reliable quantitation of HIV-1 proviral load in peripheral blood mononuclear cells
    Flavia B Lillo
    Laboratory of Virology, IRCCS Hospital San Raffaele, AIDS Center San Luigi, Via Stamira, D Ancona 20, 20127 Milan, Italy
    J Virol Methods 120:201-5. 2004
    ..Taken together, the data showed that the modified CAHIM test can be used to monitor HIV proviral DNA changes during HAART and can help in investigating further the clinical use of this marker...
  4. ncbi Human papillomavirus viral load: a possible marker for cervical disease in HIV-infected women
    Flavia B Lillo
    Laboratory of Virology, AIDS Center San Luigi, Via Stamira d Ancona 20, San Raffaele Scientific Institute, 20127 Milan, Italy
    J Antimicrob Chemother 57:810-4. 2006
    ....
  5. ncbi Human papillomavirus infection and its role in the genesis of dysplastic and neoplastic lesions of the squamous epithelia
    Flavia B Lillo
    Laboratory of Virology, IRCCS Hospital San Raffaele, Milano, Italy
    New Microbiol 28:111-8. 2005
    ....
  6. ncbi HIV-1 DNA and RNA kinetics in primary HIV infection
    F Lillo
    Laboratory of Virology, Scientific Institute San Raffaele, Milan, Italy
    J Biol Regul Homeost Agents 16:49-52. 2002
    ..To define the best method to measure low level viral replication, we determined the extent of HIV reservoir in 11 acutely infected patients and evaluated how it is renewed even during successful treatment...
  7. ncbi Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy
    F B Lillo
    Laboratory of Virology, San Raffaele Hospital, 20127 Milan, Italy
    J Infect Dis 184:547-51. 2001
    ..These results indicate that, even in the era of HAART, HIV-infected women should be monitored carefully for the emergence of high-grade SILs and cervical cancer...
  8. ncbi Granulocyte/monocyte apheresis induces sustained increases in CD4 T cells in HIV-1 infected patients with poor CD4 T cell restoration after suppression of viral replication by HAART
    H Hasson
    Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
    J Biol Regul Homeost Agents 16:58-63. 2002
    ..There was no evidence of increased viral replication during or after the apheresis cycles. The data show that monocyte apheresis is safe, well tolerated and may be indicated in patients who respond poorly to HAART...
  9. ncbi Ex-vivo purging of circulating monocytes results in immunovirologic improvement in partially HAART responder HIV-infected patients
    A Beretta
    CIRBS, Hospital St Joseph, Paris, France
    J Biol Regul Homeost Agents 14:27-31. 2000
    ..G-1 apheresis should be considered in patients in whom HAART is only partially effective...
  10. ncbi The effect of HAART on humoral immune response in primary HIV-1 infected patients
    C Pastori
    Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
    J Biol Regul Homeost Agents 16:9-17. 2002
    ..These results may be relevant for understanding how HAART may elicit a strong protective responses and may be useful in developing new strategies designed to achieve a long term control of the HIV infection...
  11. ncbi Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy
    C Barassi
    Infectious Diseases Clinic, San Raffaele Scientific Institute, via S. D'Ancona 20, 20127 Milano, Italy
    J Virol 79:6848-58. 2005
    ..These data suggest that immune strategies aimed at generating anti-CCR5 antibodies at the level of the genital mucosa might be feasible and represent a strategy to induce mucosal HIV-protective immunity...
  12. ncbi Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women
    Caterina Uberti-Foppa
    AIDS 17:2136-8. 2003
  13. ncbi Rapid and accurate quantification of different HCV genotypes by LightCycler Real Time PCR and direct sequencing of HCV amplicons
    Paola Menegazzi
    Department of Virology and Molecular Biology, Dr Pignatelli Laboratory, Lecce, Italy
    New Microbiol 31:181-7. 2008
    ..All this makes the LightCycler Real Time RT-PCR protocol a suitable tool for the diagnosis and monitoring of HCV infections...